More than half of US adults could benefit from GLP-1 medications, researchers find
Semaglutide Eligibility Among US Adults. Credit: JAMA Cardiology (2024). DOI: 10.1001/jamacardio.2024.4657 In a new analysis of national data, researchers at...
Read moreDetails